Trial intelligence / Profile preview

Proton pump inhibitors to reduce maintenance phlebotomy in hereditary hemochromatosis

NL-OMON38058Active, not recruiting

Sponsor
Maastricht University Medical Center+
Start
Sep 2013
Countries
1
01

Overview

Randomised trial in hereditary hemochromatosis (HH) (2 arms), sponsored by Maastricht University Medical Center+. Started Sep 2013; status: active, not recruiting.

02

Conditions

hereditary hemochromatosis (HH)

Beyond the preview

Go deeper on NL-OMON38058.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38058.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call